High-Mannose–Type Glycan of Basigin in Endothelial Cells Is Essential for the Opening of the Blood–Brain Barrier Induced by Hypoxia, Cyclophilin A, or Tumor Necrosis Factor-α
The American Journal of Pathology · 2024
DOI: 10.1016/j.ajpath.2023.11.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Pathology, 2024. Verfasst von Dan Cui und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Yamaguchi University Graduate School of Medicine, Ube, Japan. Hauptthemen laut MEDLINE: Basigin, Blood-Brain Barrier. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Government of Japan Ministry of Education Culture Sports Science and Technology.
Abstract (Originalsprache)
Pathologic opening of the blood-brain barrier accelerates the progression of various neural diseases. Basigin, as an essential molecule for the opening of the blood-brain barrier, is a highly glycosylated transmembrane molecule specified in barrier-forming endothelial cells. This study analyzed the involvement of basigin in the regulation of the blood-brain barrier focusing on its glycosylation forms. First, basigin was found to be expressed as cell surface molecules with complex-type glycan as well as those with high-mannose-type glycan in barrier-forming endothelial cells. Monolayers of endothelial cells with suppressed expression of basigin with high-mannose-type glycan were then prepared and exposed to pathologic stimuli. These monolayers retained their barrier-forming properties even in the presence of pathologic stimuli, although their expression of basigin with complex-type glycan was maintained. In vivo, the blood-brain barrier in mice pretreated intravenously with endoglycosidase H was protected from opening under pathologic stimuli. Pathologically opened blood-brain barrier in streptozotocin-injected mice was successfully closed by intravenous injection of endoglycosidase H. These results show that high-mannose-type glycan of the basigin molecule is essential for the opening of the blood-brain barrier and therefore a specific target for protection as well as restoration of pathologic opening of the blood-brain barrier.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Yamaguchi University Graduate School of Medicine, Ube, Japan.
- Department of Integrated Biosciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan.
- Department of Pathology, Yamaguchi University Graduate School of Medicine, Ube, Japan. Electronic address: ikedae@yamaguchi-u.ac.jp.
Förderung
- Government of Japan Ministry of Education Culture Sports Science and Technology
Zitieren
APA
Cui, D., Yamamoto, K., & Ikeda, E. (2024). High-Mannose–Type Glycan of Basigin in Endothelial Cells Is Essential for the Opening of the Blood–Brain Barrier Induced by Hypoxia, Cyclophilin A, or Tumor Necrosis Factor-α. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2023.11.007
Vancouver
Cui D, Yamamoto K, Ikeda E. High-Mannose–Type Glycan of Basigin in Endothelial Cells Is Essential for the Opening of the Blood–Brain Barrier Induced by Hypoxia, Cyclophilin A, or Tumor Necrosis Factor-α. The American Journal of Pathology. 2024. doi:10.1016/j.ajpath.2023.11.007
BibTeX
@article{Cui2024,
author = {Cui, Dan and Yamamoto, Kazuo and Ikeda, Eiji},
title = {High-Mannose–Type Glycan of Basigin in Endothelial Cells Is Essential for the Opening of the Blood–Brain Barrier Induced by Hypoxia, Cyclophilin A, or Tumor Necrosis Factor-α},
journal = {The American Journal of Pathology},
year = {2024},
doi = {10.1016/j.ajpath.2023.11.007}
}
EUVIMED